Preclinical Considerations for Products Regulated in OTP
Allen Wensky, PhD.
Allen Wensky provides a basic overview of preclinical considerations that make up one of the three key elements of an IND submission.
Presentation
- Preclinical Considerations for Products Regulated in OTP
- Preclinical Considerations for Products Regulated in OTP
Course List
- Introduction and Scope of OTP
- The Chemistry, Manufacturing and Controls (CMC) Section of a Gene Therapy IND
- Advanced Topics: Successful Development of Quality Cell and Gene Therapy Products
- Cellular Therapy Products